Saturday, May 21, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

by Medical Finance
in Coronavirus
Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are bringing together the inflammatory bowel disease (IBD) care community for the fifth annual Crohn’s & Colitis Congress®, taking place virtually Jan. 20 through 22, 2022. During the premier IBD meeting, we’ll review the latest advancements in IBD patient care to improve the lives of the millions of Americans living with Crohn’s disease and ulcerative colitis.

Below is a summary of two top studies being presented at the Crohn’s & Colitis Congress. To speak with the study authors or review all 27 abstracts being presented, email [email protected]

IBD patients with incomplete COVID-19 vaccinations are at greater risk of hospitalization

Study title: COVID-19 infections in vaccinated patients with inflammatory bowel disease: Outcomes and risk factors for severe disease

Presented by Emily Spiera, Icahn School of Medicine at Mount Sinai

Significance: There has been very little data on the impact of the coronavirus disease for vaccinated patients with inflammatory bowel disease. In this study, researchers analyzed data from the Surveillance Epidemiology of Coronavirus Under Research Exclusion in Inflammatory Bowel Disease (SECURE-IBD) database to describe outcomes and identify risk factors for severe disease from COVID-19 infection in this population. They found that in patients with IBD, incomplete vaccination, non-mRNA vaccines, and combination therapy are associated with increased risk of adverse events during breakthrough COVID-19 infections.

Higher risk for autoimmune disease, IBD, and growth failure in children of women with IBD

Study title: Long term adverse health outcomes in offspring from mothers with inflammatory bowel disease: A nationwide population-based study in Korea

Presented by Hyeong Sik Ahn, Korea University, Department of Preventive Medicine, Medical School

Significance: This is the largest study to assess the long-term influence of maternal IBD on disease, growth and development of their offspring. Using a database of 3 million women who gave birth during the study period, the researchers identified that children born to mothers with IBD were at higher risk of developing autoimmune disease and IBD. These children were also at higher risk for growth failure up to age 6 (defined as less than 3 percentiles in weight and height). There was no increased risk for other disease tracked, including neurodevelopmental disorders, metabolic diseases, autism spectrum disorder, bronchial asthma, or juvenile rheumatoid arthritis.

Four additional abstracts you may be interested in covering:

  • Cell-autonomous hedgehog signaling controls TH17 differentiation to drive intestinal inflammation and is a druggable target for the treatment of IBD
  • Corticosteroids and 5ASA versus Corticosteroids alone for acute severe ulcerative colitis: A randomized controlled trial
  • Endoscopic stricturotomy – a novel therapeutic modality for IBD-related strictures: First European experience
  • Point-of-care intestinal ultrasound for the detection of postoperative Crohn’s disease endoscopic recurrence
  • To review these abstracts or see the full abstract book.

Source:

American Gastroenterological Association

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients. Image Credit: Alexandros Michailidis/Shutterstock

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

by Medical Finance
May 20, 2022
0

In a recent cross-sectional study posted to the medRxiv* preprint server, researchers used per protocol bronchoalveolar lavage fluid (BALF) samples...

Study: The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses. Image Credit: Design_Cells / Shutterstock

Macrodomains represent a unique target for pathogens with pandemic potential

by Medical Finance
May 20, 2022
0

Scientists have long stated that the emergence and re-emergence of infectious viral diseases, such as severe acute respiratory syndrome coronavirus...

Study: Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan. Image Credit: grafvision/Shutterstock

The association between green tea consumption and SARS-CoV-2 infection among Japanese

by Medical Finance
May 20, 2022
0

A study recently published in the Clinical Nutrition Open Science journal examined the association between consumption of green tea...

Officials struggle to regulate pop-up covid testing sites — and warn patients to beware

Roe v. Wade’s (possibly last) anniversary

by Medical Finance
May 20, 2022
0

Jan. 22 is the 49th anniversary of the Supreme Court's landmark abortion ruling, Roe v. Wade, and could well be...

Study: Testing behaviour may bias observational studies of vaccine effectiveness. Image Credit: Tong_stocker/Shutterstock

Impact of SARS-CoV-2 testing behavior on observational studies of vaccine efficiency

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* pre-print server, a team of researchers performed an observational study to understand...

Study: Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages. Image Credit: Viacheslav Lopatin/Shutterstock

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the emergence and evolution of severe acute respiratory...

Next Post
Nutritional components hold promise for improving the health and well-being of adults

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

Study: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Image Credit: SKK Pix / Shutterstock

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Image Credit: Warah38 / Shutterstock
    Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses
  • By Anamaria Mejia a60125ebe2694f9e8eabf0159ee2c5ff 620x480
    Cell Guidance Systems and Manchester BIOGEL collaborate to launch PODS-PeptiGels for 3D cell culture
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply